Talking Medicines
Business Intelligence (BI) Software · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
25 Blythswood Sq, Glasgow, Glasgow, G2 4...Phone Number
+44 1412222212Website
www.talkingmedicines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Talking Medicines
Talking Medicines is revolutionising the pharmaceutical industry and the $30Bn it spend on advertising with its cutting-edge social intelligence platform, PatientMetRx®. By harnessing the power of artificial intelligence (AI) and natural language processing, the platform transforms unstructured social feedback on patient experience for pharmaceutical companies and their advertising agencies. Using Large Language Models within its advanced AI, clients can answer questions through its Drug-GPT of the highly curated patient and Health Care Professional experience to find a single source of truth. This allows companies to deliver a greater return on investment for marketing and ultimately improve health outcomes for patients. With PatientMetRx®, pharmaceutical companies have access to a level of scale and depth of patient insights that was previously impossible, enabling them to make data-driven decisions that drive success.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Talking Medicines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Talking Medicines has new funding data
Earning: See what the market has to say on Talking Medicines recently announced quarterly report
Talking Medicines, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Talking Medicines is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Talking Medicines
Product Launch: Get notified when Talking Medicines launches new products
Website visits: Recent activity has been detected on your website
Click to see if Talking Medicines had a recent Job posting/layoffs
Check if Talking Medicines has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Talking Medicines as Masked Content
Find 2 more new buyers
Compare Similar Companies to Talking Medicines
Compare insights from companies similar to Talking Medicines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Talking Medicines
<$5M
11-50
Private
<$5M
2013
N/A
<$5M
11-50
Private
<$5M
2014
CA
Carlos ArmandTechnologist & Senior Biomechanical, Design Engineer, Group Head of Design
Company Profile Activity
Activity Insights
Talking Medicines is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Talking Medicines is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Talking Medicines.
Talking Medicines financials insights
Gather financial insights about Talking Medicines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Unspecified
$841K
2020
Unspecified
$1.4M
2022
Unspecified
$2M
Talking Medicines Tech Stack
A closer look at the technologies used by Talking Medicines
Talking Medicines News & Media
Talking Medicines: World’s First Patient Voice GPT Provides Curated Insights in Seconds
JERSEY CITY, N.J.--(BUSINESS WIRE)--Healthcare marketers can now access vital insights about patients and healthcare professionals (“HCPs”) within seconds through the world’s first curated Patient Voice GPT. Health data-tech company Talking Medicines has launched Drug-GPT™ on its enhanced PatientMetRx® 2.0 platform, providing healthcare advertising agencies with access to real-world insights about the lived experience, opinions, and sentiment of patients and HCPs. Drug-GPT™ only uses Talking MePatientMetRx® Launches Patient Opinion Mapping for Fast, Accurate and Actionable Insights
GLASGOW, Scotland--(BUSINESS WIRE)--PatientMetRx®, the only data insight service which captures how patients are responding to and experiencing their medicines, has introduced a new feature enabling healthcare marketeers to gain access to specific and accurate patient insights by medicine from publicly sourced posts. Until now, healthcare brands and their creative agencies have relied upon manually extracting insights from patient reports on specific medicines – a process which is time-consuminDeals of the week January 31 to February 4 – a GrowthBusiness roundup
Deals of the Week, Jan 31-Feb 4. This week's VC deals include sustainable activewear brand Tala getting sweaty with a £4m investment.£1.5 million funding round fuels US growth for Talking Medicines - Scottish Business Insider
Glasgow-based business has established a New Jersey outpost and will now recruit a US sales team
Read more news
Top Business Intelligence (BI) Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Talking Medicines
Sign Up For FreeTo access detailed company insights
Talking Medicines is revolutionising the pharmaceutical industry and the $30Bn it spend on advertising with its cutting-edge social intelligence platform, PatientMetRx®. By harnessing the power of artificial intelligence (AI) and natural language processing, the platform transforms unstructured social feedback on patient experience for pharmaceutic... Read More
